Source Search Page
investing.com > news > company-news
Zevra Therapeutics share price target lifted, buy rating held on FDA approval By Investing.com
2+ week, 4+ day ago —...FDA approval On Tuesday, Zevra Therapeutics, Inc.... ...The analyst anticipates that Zevra Therapeutics will begin commercial... ...Zevra Therapeutics' progress with MIPLYFFA and the additional financial... ...In other recent news, JMP Securities initiated coverage on Zevra,...
investing.com > news > company-news
Schneider National stock well-positioned despite truckload market downturn - Citi By Investing.com
3+ day, 22+ hour ago —...On Wednesday, Citi initiated coverage on Schneider National (NYSE... ...The analysis by Citi suggests that if Schneider National can consistently... ...offers 5 additional tips for Schneider National, providing a deeper... ...This aligns with an InvestingPro Tip indicating that SNDR is "Trading...
investing.com > news > company-news
Wolfe Research highlights RLI Corp. shares for sustainable outperformance and growth potential By Investing.com...
3+ day, 20+ hour ago —...Wolfe Research highlights RLI Corp. shares for sustainable outperformance... ...on RLI Corp .... ...Group, RLI Corp anticipates continued organic growth by... ...RLI Corp.'...
investing.com > news > company-news
Addus HomeCare shares target raised by Oppenheimer By Investing.com
2+ week, 5+ day ago —...Oppenheimer maintained its Outperform rating on Addus HomeCare (NASDAQ... ...Following recent meetings with the management of Addus HomeCare,... ...Analysts from TD Cowen have incorporated these strategic moves into... ...as the leading provider of personal care services in Texas....
investing.com > news > company-news
Bank of New York Mellon target raised on new strategy By Investing.com
2+ week, 2+ day ago —...Bank of New York Mellon target raised on new strategy CFRA raised... ...the price target on shares of Bank of New York Mellon (NYSE:BK)... ...Commodity Futures Trading Commission (CFTC) over swap transaction-related... ...Meanwhile, Bank of New York Mellon (BNY Mellon) has been the subject...
investing.com > news > stock-market-news
Buffett's Berkshire Hathaway offloads more of its Bank of America stake By Investing.com
3+ week, 1+ day ago —...Buffett's Berkshire Hathaway offloads more of its Bank of America... ...stake Investing.com -- Warren Buffett's Berkshire Hathaway (NYSE... ...Chief Executive Brian Moynihan said that he is not in a position... ...When recently asked about Berkshire divestitures, Bank of America...
investing.com > news > company-news
Zevra Therapeutics shares keep Buy rating on FDA approval By Investing.com
1+ week, 6+ day ago —...that it did not have an FDA Advisory Committee (AdCom) review like... ...Zevra Therapeutics shares keep Buy rating on FDA approval On Monday... ...In other recent news, analyst firms including Maxim Group, Roth/MKM... ...These recent developments highlight Zevra Therapeutics' ongoing commitment...
investing.com > news > stock-market-news
Ur-Energy COO sells over $214,000 in company stock By Investing.com
2+ week, 5+ day ago —...Following the sale, Hatten's ownership in UR-Energy (NYSE:URG) Inc... ...Ur-Energy Inc.... ...As Ur-Energy Inc.... ...in Littleton, Colorado....
investing.com > news > company-news
Wall Street SWOT: AbbVie stock navigates Humira loss with promising pipeline By Investing.com
2+ week, 2+ day ago —...AbbVie, spun off from Abbott Laboratories (NYSE:ABT) in 2013, has... ...competition in the United States.... ...The success of Skyrizi and Rinvoq is crucial to offsetting Humira... ...portfolio is set to expand with the pending acquisition of Cerevel Therapeutics...
investing.com > news > company-news
TD Cowen sticks with buy rating on Vera Therapeutics, confident in upcoming clinical data By Investing.com...
5+ day, 20+ hour ago —...TD Cowen sticks with buy rating on Vera Therapeutics, confident in... ...San Diego.... ...2b ORIGIN study at the American Society of Nephrology Kidney Week... ...The company has also appointed David Johnson as its new Chief Operating...